Study of an injected drug for adults with obesity
Part of Hormones & metabolism clinical trials.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) is between 30.0 and 45.0. (BMI is a measure of weight relative to height.)
- You are not pregnant, breastfeeding, or planning to become pregnant or donate eggs during the study and for 2 months after.
- You have not lost 5% or more of your body weight in the last 3 months without a specific weight loss program.
- You do not have diabetes (HbA1c below 6.5% and blood sugar below 126 mg/dL).
- You have not taken prescription weight loss medication or been in a weight loss study in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication called ACCG-2671 to see how safe it is and how your body handles it. It's an early-stage trial, so the main focus is on safety and tolerability. The study has different parts: one for people with normal weight and one for people with higher weight who are already taking a GLP-1 injection for weight loss.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
This study tests an investigational drug called ABBV-295 to see if it helps adults with obesity or overweight who have weight-related health conditions lose weight. It may offer a new treatment option for managing weight and improving overall health.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.